Adage Capital Partners
ITCI

Adage Capital Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-298,391
Closed -$39.4M 971
2025
Q1
$39.4M Sell
298,391
-379,609
-56% -$50.1M 0.07% 277
2024
Q4
$56.6M Buy
678,000
+493,000
+266% +$41.2M 0.1% 196
2024
Q3
$13.5M Sell
185,000
-316,173
-63% -$23.1M 0.02% 550
2024
Q2
$34.3M Sell
501,173
-58,827
-11% -$4.03M 0.06% 300
2024
Q1
$38.8M Buy
560,000
+285,000
+104% +$19.7M 0.07% 288
2023
Q4
$19.7M Sell
275,000
-610,000
-69% -$43.7M 0.04% 424
2023
Q3
$46.1M Buy
885,000
+405,000
+84% +$21.1M 0.1% 214
2023
Q2
$30.4M Buy
480,000
+115,000
+32% +$7.28M 0.07% 298
2023
Q1
$19.8M Buy
+365,000
New +$19.8M 0.04% 415
2022
Q4
Sell
-305,000
Closed -$14.2M 1056
2022
Q3
$14.2M Sell
305,000
-698,271
-70% -$32.5M 0.04% 534
2022
Q2
$57.3M Buy
1,003,271
+153,271
+18% +$8.75M 0.13% 163
2022
Q1
$52M Buy
850,000
+600,000
+240% +$36.7M 0.1% 203
2021
Q4
$13.1M Sell
250,000
-50,000
-17% -$2.62M 0.02% 619
2021
Q3
$11.2M Sell
300,000
-300,000
-50% -$11.2M 0.02% 661
2021
Q2
$24.5M Sell
600,000
-200,000
-25% -$8.16M 0.05% 388
2021
Q1
$27.1M Buy
800,000
+37,583
+5% +$1.28M 0.06% 356
2020
Q4
$24.2M Buy
762,417
+362,417
+91% +$11.5M 0.05% 369
2020
Q3
$10.3M Buy
+400,000
New +$10.3M 0.03% 518
2016
Q4
Sell
-600,000
Closed -$9.14M 738
2016
Q3
$9.14M Sell
600,000
-500,000
-45% -$7.62M 0.03% 531
2016
Q2
$42.7M Hold
1,100,000
0.12% 212
2016
Q1
$30.6M Buy
1,100,000
+23,538
+2% +$654K 0.08% 273
2015
Q4
$57.9M Sell
1,076,462
-69,304
-6% -$3.73M 0.15% 179
2015
Q3
$45.9M Buy
1,145,766
+445,766
+64% +$17.8M 0.13% 213
2015
Q2
$22.4M Hold
700,000
0.06% 386
2015
Q1
$16.7M Sell
700,000
-100,000
-13% -$2.39M 0.04% 457
2014
Q4
$14.1M Buy
800,000
+50,000
+7% +$883K 0.03% 473
2014
Q3
$10.3M Buy
750,000
+300,000
+67% +$4.11M 0.03% 523
2014
Q2
$7.59M Buy
450,000
+50,000
+13% +$843K 0.02% 567
2014
Q1
$7.27M Buy
+400,000
New +$7.27M 0.02% 550